CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 360

Industry reads hand-picked by our editors

Oct 16, 2015

Huffington Post
Stop the madness: Jonathan Cohn explores a different approach to schizophrenia treatment
FiercePharma
Allergan plots 117 job cuts in the wake of Kythera buyout
Bloomberg
AstraZeneca fails to win FDA backing for diabetes treatment

Oct 15, 2015

WSJ
Hot startup Theranos has struggled with its blood-test technology
Bloomberg
Biggest biotech fund expands bet amid 'manic-depressive' market
Forbes
Pfizer's CEO faces the drug pricing firestorm

Oct 14, 2015

FiercePharma
Sources: Sanofi tells unions a 25% gain at French production sites is needed
Reuters
Germany's Merck KGaA scraps unit brands
http://www.wsj.com/articles/study-raises-new-concerns-about-bayer-sterility-device-1444775581
Study raises new concerns about Bayer sterility device

Oct 13, 2015

PR Newswire
Intrexon/ViaGen deliver litter of cloned kittens
Pharma Times
Six meds OK'd for NHS Scotland, but Novartis' Afinitor rejected
WSJ
Abbott's dissolving stent shows mixed results

Oct 12, 2015

FiercePharma
Roche CEO: Big Data needs Big Pharma, and vice versa
Reuters
Merck KGaA bets on cancer drugs to revitalize German firm
Bloomberg
This Drugmaker Suffered the Consequences of Price Increases

Oct 09, 2015

Reuters
Nestle spends $70 million on U.S. health science hub
FierceBiotech
Roche picks up new autoimmune drug with $580M Adheron deal
Pharma Times
UK experts demand trials on antivirals for flu pandemics

Oct 08, 2015

Boston Globe
People with Alzheimer's press for answers
Fast Company
FDA officially opens door to 23andMe DTC Bloom syndrome test
Reuters
Nobel discoveries on DNA repair now fueling cancer drug research

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
Inside the world of cell therapies Supported by ProBio CDMO
Trendline
Inside the market strategies of today’s drugmakers Supported by Evaluate
Trendline
The latest developments on the gene therapy frontier Supported by Mirus Bio LLC

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
2026 Life Sciences AI & Data Predictions Webinar - on demand • Provided by Snowflake

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.